<DOC>
	<DOCNO>NCT00005790</DOCNO>
	<brief_summary>RATIONALE : Perfusion magnetic resonance imaging may effective method measure growth blood vessel brain tumor . These measurement may help doctor good diagnose treat brain tumor . PURPOSE : Pilot study determine effectiveness perfusion magnetic resonance image measure growth blood vessel newly diagnose brain tumor .</brief_summary>
	<brief_title>Perfusion Magnetic Resonance Imaging Measuring Growth Blood Vessels Newly Diagnosed Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : I. Correlate finding perfusion magnetic resonance image know tissue serum marker angiogenesis patient newly diagnose surgically resectable brain tumor . OUTLINE : Patients undergo perfusion magnetic resonance imaging ( MRI ) scan contrast conjunction preoperative conventional MRI scan contrast . Patients receive gadopentetate dimeglumine IV 5 second prior perfusion MRI . Gadopentetate dimeglumine administer slow rate prior conventional MRI . Patients undergo blood draw determine urokinase type plasminogen activator level . After completion perfusion conventional MRI scanning , brain tumor tissue sample obtain surgical resection determine tumor grade type urokinase type plasminogen activator basic fibroblast growth factor level . If CSF removal require surgery , CSF sample collect determine urokinase type plasminogen activator basic fibroblast growth factor level . PROJECTED ACCRUAL : A total 10 patient accrue study .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose surgically resectable brain tumor PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Able tolerate gadopentetate dimeglumine contrast Medically stable PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult pineal parenchymal tumor</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>